Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gilles Edan

Showing results (71-80 of 149) with videos related to

Pageof 15
Sort By:
Frontiers in Immunology|May 21, 2021
Mass Cytometry Identifies Expansion of T-bet<sup>+</sup> B Cells and CD206<sup>+</sup> Monocytes in Early Multiple SclerosisLaura Couloume, Juliette Ferrant, Simon Le Gallou, et al.
Archives of Neurology|November 11, 2009
Magnetic resonance imaging predictors of conversion to multiple sclerosis in the BENEFIT studyBastiaan Moraal, Christoph Pohl, Bernard M J Uitdehaag, et al.
European Journal of Medical Genetics|November 2, 2020
ATP7A mutation with occipital horns and distal motor neuropathy: A continuumMelanie Fradin, Alinoe Lavillaureix, Sylvie Jaillard, et al.
Journal of Neurology|June 23, 2022
COPP-MS: COrticosteroids during the Post-Partum in relapsing Multiple Sclerosis patientsSoizic Leguy, Mathilde Lefort, Lucile Lescot, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 26, 2026
Serum metabolic profile at clinical onset as predictor of multiple sclerosis activity and progression after 5 yearsXiaojing Peng, Kjetil Bjornevik, Clary B Clish, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 7, 2022
Body mass index as a predictor of MS activity and progression among participants in BENEFITJuan Manuel Escobar, Marianna Cortese, Gilles Edan, et al.
Neuroimage|September 26, 2021
Multiple sclerosis lesions segmentation from multiple experts: The MICCAI 2016 challenge datasetOlivier Commowick, Michaël Kain, Romain Casey, et al.
Annals of Clinical and Translational Neurology|November 22, 2022
Multiple sclerosis clinical decision support system based on projection to reference datasetsChadia Ed-Driouch, Florent Chéneau, Françoise Simon, et al.
Lancet (London, England)|August 7, 2007
Effect of early versus delayed interferon beta-1b treatment on disability after a first clinical event suggestive of multiple sclerosis: a 3-year follow-up analysis of the BENEFIT studyLudwig Kappos, Mark S Freedman, Chris H Polman, et al.
Journal of Neurology|November 16, 2007
Subgroups of the BENEFIT study: risk of developing MS and treatment effect of interferon beta-1bChris Polman, Ludwig Kappos, Mark S Freedman, et al.
Pageof 15

Showing results (71-80 of 149) with videos related to

Sort By:
Pageof 15
Frontiers in Immunology|May 21, 2021
Mass Cytometry Identifies Expansion of T-bet<sup>+</sup> B Cells and CD206<sup>+</sup> Monocytes in Early Multiple SclerosisLaura Couloume, Juliette Ferrant, Simon Le Gallou, et al.
Archives of Neurology|November 11, 2009
Magnetic resonance imaging predictors of conversion to multiple sclerosis in the BENEFIT studyBastiaan Moraal, Christoph Pohl, Bernard M J Uitdehaag, et al.
European Journal of Medical Genetics|November 2, 2020
ATP7A mutation with occipital horns and distal motor neuropathy: A continuumMelanie Fradin, Alinoe Lavillaureix, Sylvie Jaillard, et al.
Journal of Neurology|June 23, 2022
COPP-MS: COrticosteroids during the Post-Partum in relapsing Multiple Sclerosis patientsSoizic Leguy, Mathilde Lefort, Lucile Lescot, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 26, 2026
Serum metabolic profile at clinical onset as predictor of multiple sclerosis activity and progression after 5 yearsXiaojing Peng, Kjetil Bjornevik, Clary B Clish, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 7, 2022
Body mass index as a predictor of MS activity and progression among participants in BENEFITJuan Manuel Escobar, Marianna Cortese, Gilles Edan, et al.
Neuroimage|September 26, 2021
Multiple sclerosis lesions segmentation from multiple experts: The MICCAI 2016 challenge datasetOlivier Commowick, Michaël Kain, Romain Casey, et al.
Annals of Clinical and Translational Neurology|November 22, 2022
Multiple sclerosis clinical decision support system based on projection to reference datasetsChadia Ed-Driouch, Florent Chéneau, Françoise Simon, et al.
Lancet (London, England)|August 7, 2007
Effect of early versus delayed interferon beta-1b treatment on disability after a first clinical event suggestive of multiple sclerosis: a 3-year follow-up analysis of the BENEFIT studyLudwig Kappos, Mark S Freedman, Chris H Polman, et al.
Journal of Neurology|November 16, 2007
Subgroups of the BENEFIT study: risk of developing MS and treatment effect of interferon beta-1bChris Polman, Ludwig Kappos, Mark S Freedman, et al.
Pageof 15